Concepedia

Julie A. McEarchern

JA

14

Publications

1.2K

Citations

12

H-Index

1999

Active since

Affiliations

Seagen (United States)(Current)

University of Arizona

Fred Hutch Cancer Center

University of Washington

Julie A. McEarchern is an author at Seagen (United States) specializing in immunology, medicine, and immunotherapy.

Top concepts

Publications per year

1999–2013

14

Publications

14

SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML

May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey et al. · Blood · 2013 · 381 citations

Invasion and metastasis of a mammary tumor involves TGF-? signaling

Julie A. McEarchern, James J. Kobie, Vivian Mack et al. · International Journal of Cancer · 2000 · 147 citations · Full text

Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40

Che‐Leung Law, Kristine A. Gordon, J.M. Collier et al. · Cancer Research · 2005 · 124 citations · Full text

, , +18

Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities

Julie A. McEarchern, Ezogelin Oflazoglu, Leigh Francisco et al. · Blood · 2006 · 100 citations · Full text

Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75

Maureen C. Ryan, Heather Kostner, Karen A. Gordon et al. · British Journal of Cancer · 2010 · 85 citations · Full text

Rows per page

1–5 of 14